What is PHAR's market capitalization?

Egyptian International Pharmaceutical Industries Co. has a market capitalization of about EGP 21.47B.

Does PHAR pay dividends?

Yes — Egyptian International Pharmaceutical Industries Co. has a trailing dividend yield of 2.75% (EGP 3.5 per share).

What is PHAR's P/E ratio?

Egyptian International Pharmaceutical Industries Co. trades at a trailing price-to-earnings ratio of 13.79.

Where can I track PHAR?

This Starta Markets page shows Egyptian International Pharmaceutical Industries Co.'s live EGX quote, key statistics, financial statements, dividends, technicals and news — or ask the Starta AI analyst about PHAR in Arabic or English.

Egyptian International Pharmaceutical Industries Co. (PHAR) Share Price — EGX

EGP 126.79-0.32%Technicals: Sell

Egyptian International Pharmaceutical Industries Co. (PHAR) trades on the Egyptian Exchange (EGX) in the Health Technology sector. Last updated 10 Sept 2026, 21:08 (Cairo time). EGX sector classification: Health Care & Pharmaceuticals.

What is Egyptian International Pharmaceutical Industries Co.’s share price today? PHAR last traded at EGP 126.79 (-0.32% on the day), for a market value of EGP 21.47 billion, a P/E of 13.79 and a dividend yield of 2.75%. Its 52-week range is EGP 59.27 to 160.18.

PHAR price performance

1W: -2.2%
1M: -11.3%
3M: +49.9%
6M: +63.6%
YTD: +70.5%
1Y: +115.0%
5Y: +506.6%

Total return based on EGX closing prices. Past performance does not indicate future results.

About Egyptian International Pharmaceutical Industries Co.

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally.The company provides analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolics; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products.It exports its products. The company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt.

Industry:: Pharmaceutical Preparations
ISIN:: EGS38081C013
Website:: eipico.com.eg

PHAR key statistics

Last price: EGP 126.79
Previous close: EGP 127.2
Day change: -0.32%
52-week range: EGP 59.27 – 160.18
Volume: 403,600
Shares outstanding: 168.76M
Free float: 31.64%
Market cap: EGP 21.47B
P/E (trailing): 13.79
P/B: 3.43
Dividend yield: 2.75%
EPS (TTM): EGP 9.2
Revenue (TTM): EGP 9.44B
Net income (TTM): EGP 1.44B
ROE: 26.46%
Book value / share: EGP 37
Beta (1Y): 0.38
50-day MA: EGP 115.54
200-day MA: EGP 89.36
RSI (14): 50.22

Data as of 10 Sept 2026, 21:08 (Cairo time). Source: Egyptian Exchange via TradingView; financial statements via Yahoo Finance. Prices refresh every 15 minutes during EGX trading hours (Sun–Thu).

Compare with other Health Technology stocks

Latest Egyptian International Pharmaceutical Industries Co. news

Key terms behind the PHAR figures

Market Capitalization: Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio: The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio: The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield: Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is Egyptian International Pharmaceutical Industries Co. (PHAR) share price today?: Egyptian International Pharmaceutical Industries Co. last traded at EGP 126.79 on the Egyptian Exchange (as of 10 Sept 2026, 21:08, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is PHAR's market capitalization?: Egyptian International Pharmaceutical Industries Co. has a market capitalization of about EGP 21.47B.
Does PHAR pay dividends?: Yes — Egyptian International Pharmaceutical Industries Co. has a trailing dividend yield of 2.75% (EGP 3.5 per share).
What is PHAR's P/E ratio?: Egyptian International Pharmaceutical Industries Co. trades at a trailing price-to-earnings ratio of 13.79.
What sector is Egyptian International Pharmaceutical Industries Co. in?: Egyptian International Pharmaceutical Industries Co. is listed on the Egyptian Exchange (EGX) in the Health Technology sector.
Where can I track PHAR?: This Starta Markets page shows Egyptian International Pharmaceutical Industries Co.'s live EGX quote, key statistics, financial statements, dividends, technicals and news — or ask the Starta AI analyst about PHAR in Arabic or English.